These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis. Koenig W Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518 [TBL] [Abstract][Full Text] [Related]
10. [What are the biomarkers of atherosclerosis and cardiovascular risk?]. Riesen WF Rev Med Suisse; 2008 Mar; 4(148):636-8, 640-3. PubMed ID: 18459658 [TBL] [Abstract][Full Text] [Related]
11. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689 [TBL] [Abstract][Full Text] [Related]
12. Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. McGeechan K; Macaskill P; Irwig L; Liew G; Wong TY Arch Intern Med; 2008 Nov; 168(21):2304-10. PubMed ID: 19029492 [TBL] [Abstract][Full Text] [Related]
14. Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search. Zhou X; Wang H; Wang J; Wang Y; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Chang SF; Wong ST Proteomics; 2009 Apr; 9(8):2286-94. PubMed ID: 19337989 [TBL] [Abstract][Full Text] [Related]
15. Computational prediction models for early detection of risk of cardiovascular events using mass spectrometry data. Pham TD; Wang H; Zhou X; Beck D; Brandl M; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Wong ST IEEE Trans Inf Technol Biomed; 2008 Sep; 12(5):636-43. PubMed ID: 18779078 [TBL] [Abstract][Full Text] [Related]
16. [Evidence-based medicine and cardiovascular risk stratification aimed to drug reimbursement: uselessness of risk charts]. Pujia A Ital Heart J Suppl; 2004 Aug; 5(8):661-3. PubMed ID: 15554022 [No Abstract] [Full Text] [Related]
17. Multiple biomarkers and cardiovascular risk. Austin MJ; Heneghan MA N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791 [No Abstract] [Full Text] [Related]
18. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events. Dennison CR; Hughes S J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796 [No Abstract] [Full Text] [Related]
19. Associations between migraine and cardiovascular disease. Kurth T Expert Rev Neurother; 2007 Sep; 7(9):1097-104. PubMed ID: 17868009 [TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target. Carlquist JF; Muhlestein JB; Anderson JL Expert Rev Mol Diagn; 2007 Sep; 7(5):511-7. PubMed ID: 17892360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]